Abstract
Human endosomal Toll-like receptors TLR7 and TLR8 recognize self and non-self RNA ligands, and are important mediators of innate immunity and autoimmune pathogenesis. TLR7 and TLR8 are encoded by the adjacent X-linked genes, TLR7 and TLR8. We previously established that TLR7 evades X chromosome inactivation in female immune cells, and that mononuclear blood cells express more TLR7 protein in women than in men. Using RNA fluorescence in situ hybridization, we now show that TLR8 likewise evades X chromosome inactivation in CD14+ monocytes and CD4+ T lymphocytes, and that cells harboring TLR7 or TLR8 transcript foci are more frequent in women than in men. In parallel, we found TLR7 and TLR8 simultaneous transcription to be disproportionally frequent in female monocytes and T cells, and disproportionally scarce in the male cells, resulting in a 7-fold difference in frequency. These transcriptional biases were again observable when comparing the single X of XY males with the active X of female cells. Among (47,XXY) Klinefelter syndrome males, both TLR7 and TLR8 escape X chromosome inactivation, and co-transcription frequencies on the active X of monocytes were intermediate overall between those for XY males and XX females, and encompassed both male- and female-like individual patterns. These findings indicate that the TLR7 and TLR8 genes form a co-regulated gene cluster, which we have called the X-linked Toll-like receptor locus, with different sex- and sexual karyotype-dependent modes of transcription. Interestingly, TLR8 protein expression was significantly higher in female mononuclear blood cells, including all monocyte subsets, than in the male cells. Thus, co-dependent transcription from the active X chromosome and escape from inactivation could both contribute to higher TLR8 protein abundance in female cells, which may have implications for the response to viruses and bacteria, and the risk of developing inflammatory and autoimmune diseases.
Highlights
TLR8, like TLR7, escapes X chromosome inactivation in immune cells from women and 47,XXY Klinefelter syndrome (KS) men.
The frequency of cells double-positive for TLR7 and TLR8 primary transcripts is 7-fold higher in women than in men.
TLR7 and TLR8 form a co-regulated gene cluster on the human X chromosome, with sex-specific, divergent transcriptional patterns observable in monocytes and CD4+ T lymphocytes.
Co-dependent transcription of the TLR7 and TLR8 genes on the active X was observed in women and KS men, contrasting with mutually exclusive transcription in euploid men.
Blood mononuclear cells, including monocyte subsets, expressed higher levels of TLR8 protein in females than in males.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the Scleroderma Foundation to FJB and JCG, and from the FOREUM Foundation for Research in Rheumatology to JCG. JCG is supported by further grants from the Agence Nationale de la Recherche (ANR-20-CE15-0014; ANR-20-COV8-0004-01), Fondation pour la Recherche Medicale (DEQ20180339187), the Inspire Program from Region Occitanie/Pyrenees-Mediterranee (#1901175), and the European Regional Development Fund (MP0022856). BFL was supported by a post-doctoral fellowship from the Inspire Program from Region Occitanie/Pyrenees-Mediterranee (#1901175). AY was supported by a fellowship from SIDACTION, CSL Behring Research funds, an award from Fondation des Treilles, and a bursary from Association de la Charite des Jeunes de Kafarsir, (Lebanon).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Peripheral blood mononuclear cells of anonymous, healthy blood donors at the Toulouse blood transfusion center (Etablissement Français du Sang) were from an in-house biobank approved by the competent ethics board (Comité de Protection des Personnes Sud-Ouest et Outre-Mer II, Toulouse) under reference 2-15-36. Klinefelter syndrome males were enrolled at the Toulouse University Hospital, and their study was approved by the aforementioned ethics board under reference 1-16-28. Written consent was obtained from each patient or, for child participants, from the legal guardian.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
